Novo Nordisk A/S | NOVOB - Gross Profit On Sales

Stock Price
236.10
Daily Change
-4.00 -1.67%
Monthly
-4.39%
Yearly
-42.35%
Q2 Forecast
224.75

Novo Nordisk reported DKK64.01B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
Bausch Health Companies USD 1.93B 165M Sep/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Merck USD 13.42B 431M Sep/2025
Novartis USD 10.25B 570M Dec/2025
Novo Nordisk DKK 64.01B 1.19B Jun/2025
Novo Nordisk DKK 64.01B 1.19B Jun/2025
Pacira USD 142.25M 11.34M Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Supernus Pharmaceuticals USD 164.04M 15.23M Dec/2025